Segmentation of pre- and posttreatment diffuse glioma tissue subregions including resection cavities.

Saif Baig Igor VidićGeorge M MastorakosRobert X SmithNathan WhiteSuzie Bash Anders M DaleCarrie R McDonaldThomas Beaumont Tyler M Seibert Jona A Hattangadi-GluthSantosh KesariNikdokht Farid Jeffrey D Rudie

Published in: Neuro-oncology advances (2024)

Neural networks that accurately segment pre- and posttreatment diffuse gliomas have the potential to improve response assessment in clinical trials and reduce provider burden and errors in measurement.

Keyphrases

neural network
clinical trial
low grade
high grade
primary care
deep learning
convolutional neural network
patient safety
risk factors
emergency department
randomized controlled trial
human health
adverse drug
risk assessment
phase ii
open label
drug induced
clinical evaluation